 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Baldwin Brothers LLC MA increased its stake in AstraZeneca PLC (NASDAQ:AZN  Free Report) by 4.2% during the 2nd quarter, according to the company in its most recent 13F filing with the...

AstraZeneca PLC (NASDAQ:AZN) Stake Boosted by Baldwin Brothers LLC MA

AstraZeneca PLC (NASDAQ:AZN  Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Investors purchased 30,334 put options on the company. This is an...

Traders Purchase High Volume of AstraZeneca Put Options (NASDAQ:AZN)

On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope PR Newswire VANCOUVER, British Columbia, Sept...

On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

First Citizens Financial Corp acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN  Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities...

First Citizens Financial Corp Purchases New Position in AstraZeneca PLC (NASDAQ:AZN)

Shares of AstraZeneca PLC (NASDAQ:AZN  Get Free Report) have received an average recommendation of Moderate Buy from the six brokerages that are covering the stock...

AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

AstraZeneca says Enhertu recommended for approval in EU by CHMP

Thrivent Financial for Lutherans grew its stake in shares of AstraZeneca PLC (NASDAQ:AZN  Free Report) by 66.8% during the first quarter, according to the company in its most recent...

AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Thrivent Financial for Lutherans

Surgical Outcomes of Perioperative Durvalumab in AEGEAN Study to be Presented at IASLC 2023 World Conference on Lung Cancer Surgical Outcomes of Perioperative Durvalumab in AEGEAN Study to be...

Surgical Outcomes of Perioperative Durvalumab in AEGEAN Study to be Presented at IASLC 2023 World Conference on Lung Cancer

Fred Alger Management LLC reduced its holdings in AstraZeneca PLC (NASDAQ:AZN  Free Report) by 1.9% in the 1st quarter, according to the company in its most recent filing with the SEC. The...

Fred Alger Management LLC Has $77.29 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca announces results from FLAURA2 trial

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Watchers	18,232
52-Wk Low	$52.65
52-Wk High	$76.56

Market Cap	$210.26B
Volume (M)	5.28M
52-Wk High	$76.56
52-Wk Low	$52.65

AZN AstraZeneca PLC

About

Feed

News

Sentiment

Fundamentals